Sabra Health Care REIT (SBRA) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for June 12, 2025, at company headquarters in Tustin, California.
Shareholders are invited to vote on key proposals, including director elections, executive compensation, and auditor ratification.
Voting matters and shareholder proposals
Election of seven directors is on the ballot, with all nominees recommended by the board.
Advisory vote on the compensation of named executive officers is included.
Ratification of PricewaterhouseCoopers LLP as the independent auditor for fiscal year ending December 31, 2025.
Additional business may be transacted as appropriate during the meeting.
Board of directors and corporate governance
Seven director nominees are listed: Craig A. Barbarosh, Katie Cusack, Michael J. Foster, Lynne S. Katzmann, Ann Kono, Jeffrey A. Malehorn, and Richard K. Matros.
Board recommends voting in favor of all director nominees.
Latest events from Sabra Health Care REIT
- Q2 2026 delivered strong investment and NOI growth, but a net loss from a major loan write-off.SBRA
Q2 2026 - Q1 2026 saw strong earnings, robust investments, and reaffirmed guidance for continued growth.SBRA
Q1 2026 - Proxy covers director elections, auditor ratification, and performance-based executive pay.SBRA
Proxy filing - Annual meeting seeks votes on directors, auditor, and executive pay, all board-recommended.SBRA
Proxy filing - Q4 2025 saw strong managed senior housing growth and robust 2026 guidance for ~5% FFO/AFFO growth.SBRA
Q4 2025 - Director elections, auditor ratification, and executive pay highlight strong governance and ESG.SBRA
Proxy Filing - Q3 2024 saw strong earnings, raised guidance, and robust liquidity amid sector growth.SBRA
Q3 2024 - 2024 guidance raised as managed senior housing and FFO/AFFO growth accelerate.SBRA
Q2 2024 - Q4 2024 saw strong managed senior housing growth, improved leverage, and a positive 2025 outlook.SBRA
Q4 2024